Lazard Asset Management’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $495K | Buy |
74,919
+65,410
| +688% | +$432K | ﹤0.01% | 1497 |
|
|
2025
Q1 | $87K | Sell |
9,509
-1,009
| -10% | -$9.23K | ﹤0.01% | 1841 |
|
|
2024
Q4 | $110K | Sell |
10,518
-2,098
| -17% | -$21.9K | ﹤0.01% | 1778 |
|
|
2024
Q3 | $150K | Buy |
12,616
+26
| +0.2% | +$309 | ﹤0.01% | 1674 |
|
|
2024
Q2 | $72K | Buy |
12,590
+4,844
| +63% | +$27.7K | ﹤0.01% | 1849 |
|
|
2024
Q1 | $40K | Buy |
+7,746
| New | +$40K | ﹤0.01% | 1762 |
|
|
2022
Q3 | – | Sell |
-7,007
| Closed | -$47K | – | 2321 |
|
|
2022
Q2 | $47K | Buy |
7,007
+3,875
| +124% | +$26K | ﹤0.01% | 1840 |
|
|
2022
Q1 | $44K | Buy |
3,132
+1,733
| +124% | +$24.3K | ﹤0.01% | 1803 |
|
|
2021
Q4 | $20K | Buy |
+1,399
| New | +$20K | ﹤0.01% | 2044 |
|